INFLUENCE OF THE RECOMBINANT TUMOR NECROSIS FACTOR THYMOSIN-α1 ON ANGIOGENESIS IN DISSEMINATED SKIN MELANOMA PATIENTS

by I. A. KOROLEVA, E. G. SLAVINA, A. I. CHERTKOVA, V. A. NURTDINOVA, E. K. SHOUA, M. E. ABRAMOV, Z. G. KADAGIDZE
Published 2017-06-01

IMMUNITY IN PATIENTS WITH TROPHOBLASTIC DISEASE

by B. O. Toloknov, E. G. Slavina, Z. G. Kadagidze, K. P. Laktionov, Е. Е. Makhova, A. I. Chertkova, I. V. Markina
Published 2014-09-01

THE MAIN PARAMETERS OF CELLULAR IMMUNITY IN PATIENTS WITH TRIPLE-NEGATIVE BREAST CANCER: RELATIONSHIP WITH EFFICIENCY OF CHEMOTHERAPY

by A. I. Chertkova, E. G. Slavina, E. K. Shoua, L. G. Zhukova, M. A. Okruzhnova, V. A. Nurtdinova, A. A. Borunova, N. Т. Dzhgamadze, Z. G. Kadagidze
Published 2018-11-01

ASSOCIATION OF NKT- AND ACTIVATED CD25⁺ PERIPHERAL BLOOD LYMPHOCYTES WITH DISEASE FREE AND OVERALL SURVIVAL OF TRIPLE NEGATIVE BREAST CANCER PATIENTS

by A. I. Chertkova, E. G. Slavina, T. N. Zabotina, Z. G. Kadagidze, E. K. Shoua, O. O. Gordeeva, I. V. Kolyadina, L. G. Zhukova, I. P. Gan’shina, A. A. Meshcheryakov
Published 2020-12-01